FDA Approves Two Generic Medications for Opioid Dependence Treatment Mylan Technologies Inc. and Dr. Reddy’s Laboratories SA have received the go-ahead to market buprenorphine and naloxone sublingual film. These...
FDA Approves Non-Opioid Drug to Treat Opioid Withdrawal Symptoms The US Food and Drug Administration (FDA) has approved Lucemyra (lofexidine hydrochloride) to treat opioid withdrawal symptoms in adults. This...
DEA Suspends Louisiana Pharmacy Distributor Over Suspicious Orders The Drug Enforcement Administration (DEA) announced that it has issued and served a Suspension Order on Morris & Dickson Company. The...
The American Dental Association its members to reduce the number of opioid painkillers they are prescribing. The Association announced a new policy stating that members should “essentially eliminate” opioids...
Researchers at New York’s Mt. Sinai Medical Center have pinpointed a specific protein produced by the body’s immune system which may be responsible for a person becoming addicted to...
Legislators and other policy makers throughout the country continue their efforts to combat the drug epidemic in America, especially with regards to heroin and other opiates. For example, lawmakers...
There continues to be a high demand for medication-assisted treatment (MAT) for opioid addiction. To date, however, states like Ohio only haveabout two percent of doctors that have completed...
The results of a published study confirm that when young men drink alcohol, they are putting themselves at a higher level of risk for severe liver disease over time....
For a number of patients, their first introduction to opioid pain medications occurs when they seek treatment in an Emergency Room (ER). Since doctors have more than one option...